Ferrareze PAG, Pereira e Costa RA, Thompson CE. Genomic characterization and molecular evolution of human Monkeypox viruses. Arch Virol. 2023;168:278.
Article CAS PubMed Google Scholar
Lu J, Xing H, Wang C, Tang M, Wu C, Ye F, et al. Mpox (formerly monkeypox): pathogenesis, prevention and treatment. Signal Transduct Target Ther. 2023;8:458.
Article CAS PubMed PubMed Central Google Scholar
Jafari K, Woodward GA. Mpox Pediatr Emer Care. 2023;39:883–9.
Americo JL, Earl PL, Moss B. Virulence differences of Mpox (monkeypox) virus clades I, iia, and iib.1 in a small animal model. Proc Natl Acad Sci USA. 2023;120:e2220415120.
Article CAS PubMed PubMed Central Google Scholar
Monzón S, Varona S, Negredo A, Vidal-Freire S, Patiño-Galindo JA, Ferressini-Gerpe N, et al. Monkeypox virus genomic accordion strategies. Nat Commun. 2024;15:3059.
Article PubMed PubMed Central Google Scholar
Vakaniaki EH, Kacita C, Kinganda-Lusamaki E, O’Toole Á, Wawina-Bokalanga T, Mukadi-Bamuleka D, et al. Sustained human outbreak of a new MPXV clade I lineage in Eastern Democratic Republic of the congo. Nat Med. 2024;30:2791–5.
Article CAS PubMed PubMed Central Google Scholar
Gostin LO, Jha AK, Finch A. The Mpox global health Emergency — A time for solidarity and equity. N Engl J Med. 2024;391:1265–7.
Meo SA, Al-Khlaiwi T, Jassir FFA, Meo AS. Impact of traveling on transmission trends of human Monkeypox disease: worldwide data based observational analysis. Front Public Health. 2023;11:1029215.
Article PubMed PubMed Central Google Scholar
CDC. Mpox in the United States and Around the World: Current Situation [Internet]. Mpox. 2024 [cited 2024 Oct 20]. Available from: https://www.cdc.gov/mpox/situation-summary/index.html
Mpox. - Sweden [Internet]. [cited 2024 Oct 20]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON531
Epidemiological update: Mpox due to monkeypox virus clade I [Internet]. 2024 [cited 2024 Oct 20]. Available from: https://www.ecdc.europa.eu/en/news-events/epidemiological-update-mpox-due-monkeypox-virus-clade-i
News. Mpox: Current situation - Health Protection Surveillance Centre [Internet]. [cited 2025 Jan 30]. Available from: https://www.hpsc.ie/news/title-24610-en.html
Atkinson B, Gould S, Nicholls I, Manzoor KN, Smith J, Hindle AJ, et al. Air and surface sampling for clade Ib Monkeypox virus in united Kingdom hospitals, 2024 to 2025. Euro Surveill. 2025;30:2500288.
Article PubMed PubMed Central Google Scholar
Global Mpox Trends [Internet]. [cited 2025 Feb 15]. Available from: https://worldhealthorg.shinyapps.io/mpx_global/#4_Global_situation_update
Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox virus infection in humans across 16 Countries — April–June 2022. N Engl J Med. 2022;387:679–91.
Article CAS PubMed Google Scholar
Mitjà O, Ogoina D, Titanji BK, Galvan C, Muyembe J-J, Marks M, et al. Monkeypox Lancet (London England). 2022;401:60.
Patel A, Bilinska J, Tam JCH, Fontoura DDS, Mason CY, Daunt A, et al. Clinical features and novel presentations of human Monkeypox in a central London centre during the 2022 outbreak: descriptive case series. BMJ. 2022;378:e072410.
Article PubMed PubMed Central Google Scholar
Ahmed SK, Mohamed MG, Dabou EA, Abuijlan I, Chandran D, El-Shall NA, et al. Monkeypox (mpox) in immunosuppressed patients. F1000Research. 2023;12:127.
Article CAS PubMed PubMed Central Google Scholar
Wawina-Bokalanga T, Akil-Bandali P, Kinganda-Lusamaki E, Lokilo E, Jansen D, Amuri-Aziza A, et al. Co-circulation of Monkeypox virus subclades Ia and Ib in Kinshasa province, Democratic Republic of the congo, July to August 2024. Eurosurveillance. 2024;29:2400592.
Article PubMed PubMed Central Google Scholar
Brosius I, Vakaniaki EH, Mukari G, Munganga P, Tshomba JC, De Vos E, et al. Epidemiological and clinical features of Mpox during the clade Ib outbreak in South kivu, Democratic Republic of the congo: a prospective cohort study. Lancet. 2025;405:547–59.
Pittman PR, Martin JW, Kingebeni PM, Tamfum J-JM, Mwema G, Wan Q, et al. Clinical characterization and placental pathology of Mpox infection in hospitalized patients in the Democratic Republic of the congo. PLoS Negl Trop Dis. 2023;17:e0010384.
Article CAS PubMed PubMed Central Google Scholar
Marziano V, Guzzetta G, Longini I, Merler S. Epidemiologic quantities for Monkeypox virus clade I from historical data with implications for current outbreaks, Democratic Republic of the congo. Emerg Infect Dis. 2024;30:2042.
Article PubMed PubMed Central Google Scholar
Schwartz DA. High rates of miscarriage and stillbirth among pregnant women with clade I Mpox (Monkeypox) are confirmed during 2023–2024 DR congo outbreak in South Kivu Province. Viruses. 2024;16:1123.
Article PubMed PubMed Central Google Scholar
Beiras CG, Malembi E, Escrig-Sarreta R, Ahuka S, Mbala P, Mavoko HM, et al. Concurrent outbreaks of Mpox in Africa-an update. Lancet. 2025;405:86–96.
CDC, Clade. I Mpox in Children in Africa and Expectations for Transmission in the United States [Internet]. Mpox. 2024 [cited 2024 Oct 17]. Available from: https://www.cdc.gov/mpox/php/data-research/clade-i-mpox-in-children-in-africa-and-potential-impacts-on-children-in-the-united-states.html
Barkati S, Harrison LB, Klein MB, Norman FF. Mpox in 2023: current epidemiology and management. Curr Infect Dis Rep. 2023;25:199–209.
Rao AK, Schrodt CA, Minhaj FS, Waltenburg MA, Cash-Goldwasser S, Yu Y, et al. Interim clinical treatment considerations for severe manifestations of Mpox — United states, February 2023. Morb Mortal Wkly Rep. 2023;72:232.
null null. Tecovirimat for clade I MPXV infection in the Democratic Republic of congo. N Engl J Med. 2025;392:1484–96.
Saied AA, Dhawan M, Metwally AA, Fahrni ML, Choudhary P, Choudhary OP. Disease history, pathogenesis, diagnostics, and therapeutics for human Monkeypox disease: A comprehensive review. Vaccines. 2022;10:2091.
Article CAS PubMed PubMed Central Google Scholar
Titanji BK, Eick-Cost A, Marconi VC. Effectiveness of smallpox vaccination to prevent Mpox in military personnel. N Engl J Med. 2023;389:1147.
Article PubMed PubMed Central Google Scholar
Deputy NP, Deckert J, Chard AN, Sandberg N, Moulia DL, Barkley E, et al. Vaccine effectiveness of JYNNEOS against Mpox disease in the united States. N Engl J Med. 2023;388:2434–43.
Article CAS PubMed PubMed Central Google Scholar
Mucker EM, Freyn AW, Bixler SL, Cizmeci D, Atyeo C, Earl PL, et al. Comparison of protection against Mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates. Cell. 2024;187:5540–e555310.
Article CAS PubMed Google Scholar
Dashraath P, Nielsen-Saines K, Mattar C, Musso D, Tambyah P, Baud D. Guidelines for pregnant individuals with Monkeypox virus exposure. Lancet. 2022;400:21–2.
Article PubMed PubMed Central Google Scholar
Vaccines | Smallpox | CDC [Internet]. 2022 [cited 2024 Oct 18]. Available from: https://www.cdc.gov/smallpox/clinicians/vaccines.html
Christodoulidou MM, Mabbott NA. Efficacy of smallpox vaccines against Mpox infections in humans. Immunotherapy Adv. 2023;3:ltad020.
Mason LMK, Betancur E, Riera-Montes M, Lienert F, Scheele S. MVA-BN vaccine effectiveness: A systematic review of real-world evidence in outbreak settings. Vaccine. 2024;42:126409.
Article CAS PubMed Google Scholar
Health Alert Network (HAN). – 00516 | Prevention Strategies for Mpox, including Vaccinating People at Risk via Sexual Exposure, for U.S. Travelers Visiting Countries with Clade I Mpox Outbreaks [Internet]. 2024 [cited 2024 Oct 20]. Available from: https://emergency.cdc.gov/han/2024/han00516.asp
Mpox. (Monkeypox) [Internet]. Africa CDC. [cited 2025 Jun 2]. Available from:
Comments (0)